柴胡加龙骨牡蛎汤联合125I放射性粒子植入术治疗肺癌患者精神抑郁方法探析

摘要/Abstract

摘要： 近年来，肺癌的发病率呈逐年上升趋势，且肺癌患者多合并不同程度的精神抑郁，对患者及家庭生活造成沉重负担。柴胡加龙骨牡蛎汤作为中医解郁类名方，因其立法精妙广泛应用于肿瘤患者精神抑郁的治疗。125I放射性粒子植入治疗肺部恶性肿瘤目前已在国内外广泛开展，大量文献证实这种治疗方式能取得良好疗效。本研究拟就柴胡加龙骨牡蛎汤和125I放射性粒子植入术治疗肿瘤国内外研究进展进行综述，以期探索柴胡加龙骨牡蛎汤联合125I放射性粒子植入术治疗肺癌的可行性，为肺癌患者精神抑郁的治疗方法提供参考和借鉴。

关键词: font-size:medium, ">柴胡加龙骨牡蛎汤；125I放射性粒子；肺癌患者精神抑郁

Abstract: In recent years， the incidence rate of lung cancer is increasing year by year， and lung cancer patients are often with the complication of different degrees of mental depression， which will cause heavy burden on patients and life. Chaihu plus longgu oyster decoction， as a famous prescription for relieving depression in traditional Chinese medicine， is widely used to treat tumor associated mental depression because of its exquisite legislation. 125I radioactive particles implantation in the treatment of lung malignant tumor has been widely carried out in China and abroad. A large number of literatures have confirmed that this treatment can achieve good curative effect. This article reviews the research progress of Chaihu plus longgu oyster decoction and 125I radioactive particles implantation in the treatment of tumor in China and abroad， in order to explore the feasibility and find a more effective treatment for lung cancer patients with mental depression.

Key words: font-size:medium, ">Chaihu plus longgu oyster decoction；125I radioactive particles； Lung cancer patients with mental depression

中图分类号:

吴思琪, 李毅俊, 孙伟芬. 柴胡加龙骨牡蛎汤联合125I放射性粒子植入术治疗肺癌患者精神抑郁方法探析[J]. 中国医药导刊, 2021, 23(4): 264-267.

WU Siqi, LI Yijun, SUN Weifen. The Method Analysis of Chaihu Plus Longgu Oyster Decoction Combined with 125I Radioactive Particles Implantation in the Treatment of Lung Cancer Patients with Mental Depression[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2021, 23(4): 264-267.

参考文献

[1]Bray F， Ferlay J， Soerjomataram I， et al. Global cancer statistics 2018 GL-OBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin， 2018，68(6)：394-424.
     [2]Siegel RL， Miller KD， Jemal A. Cancer statistics， 2019[J]. CA Cancer J Clin，2019，69(1)：7-34.
     [3]Walker J， Hansen C H， Martin P， et al. Prevalence， associations， and adequacy of treatment of major depression in patients with cancer： a cross-sectional analysis of routinely collected clinical data[J]. The Lancet Psychiatry， 2014，1(5)：343-350.
     [4]孙广仁，郑洪新. 中医基础理论[M]. 北京：中国中医药出版社， 2012：10.
     [5]Schidkraut JJ， Gordon EK， Durell J. Catecholamine metabolism in affective disorders I Normetanephrine and VMA excretion in depressed patients treated with imipramine[J]. J Psychiatr Res， 1965，3(4)：213-218.
     [6]Yaniv SP， Lueckj A， Klein E， et al. Dexamethasone enhances the norepinephrine-induced ERK /MAPK intracellular pathwaypossibly via dysregulation of the alpha2-adrenergic receptor： implications for antidepressant drug echanism of action[J]. Eur Jcell Biol， 2010，89(9)：712-722.
     [7]Ferres-Coy A， Santana N， Castane A， et al. Acute 5-HT(1A) autoreceptor knockdown increases antidepressant response and serotonin release in stressful conditions[J]. Psychopharmacology ( Berl)， 2013，225(1)：61-74.
     [8]Stahl SM， Lee-zimmaman C， Cartwriqht S， et al. Serotonergic drugs for depression and beyond[J]. Curr Drug Targets， 2013，14(5)：578-585.
     [9]Janowsky DS， El-Yousef MK， Davis JM， et al. A cholinergic-adrenergic hypothesis of mania and depression[J]. Lancet， 1972，2(7778)：632-635.
     [10]Hryhorczuk C， Sharma S， Fulton SE. Metabolic disturbances connecting obesity and depression[J]. Front Neurosci， 2013，7(10)：1-14.
     [11]Whybrow PC， Prange AJ Jr. A hypothesis of thyroid-cate-cholamine-receptor interaction. Its relevance to affective illness[J]. Arch Gen Psychiatry， 1981，38(1)：106-113.
     [12]Oliveira SL， Pillat MM， Cheffer A， et al. Functions of neurotrophins and growth factors in neurogenesis and brain repair[J]. Cytometry A， 2013，83(1)：76-89.
     [13]孙立忠，靳桂丽. 精神病学分册[M]. 吉林：吉林大学出版社， 2010：204-205.
     [14]刘渡舟. 伤寒论讲稿[M]. 北京：人民卫生出版社， 2008：115-117.
     [15]宋敬东. 中医四大名著[M]. 天津：天津科学技术出版社， 2017：346.
     [16]周秋丽，王涛，王本祥. 现代中药基础研究与临床[M]. 天津：天津科技翻译出版公司， 2012：1031-1037，607-609.
     [17]戈宏焱，陈博，许丹，等. 柴胡皂苷A对抑郁模型大鼠脑中单胺类神经递质及其代谢产物含量的影响[J]. 高等学校化学学报， 2008，29(8)：1535-1538.
     [18]张骞，陈成群. 柴胡加龙骨牡蛎汤在恶性肿瘤化疗后并发抑郁症患者中的治疗效果[J]. 临床研究， 2019，27(4)：133-134.
     [19]姜爱萍. 柴胡加龙骨牡蛎汤加减方治疗乳腺癌并发抑郁患者的临床分析[J]. 世界最新医学信息文摘（连续型电子期刊）， 2019，19(A1)： 204， 206.
     [20]于慧. 柴胡加龙骨牡蛎汤治疗肿瘤化疗后并发抑郁症的临床分析[J]. 中国中医药现代远程教育， 2018，16(3)：55-56.
     [21]王锦辉. 柴胡加龙骨牡蛎汤加减治疗肿瘤后抑郁50例[J]. 陕西中医， 2016，37(9)：1205-1206.
     [22]王健华，王锦辉，杨俊泉，等. 柴胡加龙骨牡蛎汤加减方治疗乳腺癌并发抑郁患者的临床研究[J]. 中国煤炭工业医学杂志， 2016，19(5)：732-736.
     [23]Konaka H， Egawa S， Saito S， et al. Tri-Modality therapy with I-125 brachytherapy， external beam radiation therapy， and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP)： study protocol for a phase III， multicenter， randomized， controlled trial[J]. BMC Cancer， 2012，12： 110.
     [24]柴树德，郑广钧. 胸部肿瘤放射性粒子治疗学[M]. 北京：人民卫生出版社， 2012：4-10.
     [25]Smith R P， Schuchert M， Komanduri K， et al. Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants： implications for ACOSOG z4032[J]. Ann Surg Oncol， 2007，14(12)：3610-3613.
     [26]孙燕，周际昌. 临床肿瘤内科手册[M]. 北京：人民卫生出版社， 2004： 268-269.
     [27]Balagurumoorthy P， Xu X， Wang K， et al. Effect of distance between decaying125 I and DNA on auger-electron induced double-strand break yield[J]. International J Radiation Biol， 2012，88(12)：998-1008.
     [28]Park HJ， Lyons JC， Ohtsubo T， et al. Cell cycle progres-sion and apoptosis after irradiation in an acidic environment[J]. Cell Death Differ， 2000，7：729-738.
     [29]Wei GZ， Yin XW. Clinical application of CT-guided interstitial implantation of 125I for the treatment of pulmonary carcinoma[J]. Chin J Min Inv Surg， 2008，8(3)： 243-245.
     [30]Chen H H，Jia R F，Yu L，et al. Bystander effects induced by continuous low-dose-rate 125 I seeds potentiate the killing action of irradiation on human lung cancer cells in vitro[J]. Int J Radiat Oncol Biol Phys， 2008，72 (5)：1560-1566.
     [31]Cheng J， Ma S， Yang G， et al. The Mechanism of Computed Tomography-Guided 125I Particle in Treating Lung Cancer[J]. Med Sci Monit， 2017，23：292-299.
     [32]Wang Z， Zhao Z， Lu J， et al. A Comparison of the biological effects of 125I seeds continuous low-dose-rate radiation and 60Co high-dose-rate gamma radiation on non-small cell lung cancer cells[J]. PLoS ONE， 2015，10(8)：e133728.
     [33]Qu A，Wang H，Wang J，et al. I-125 Seeds Continuous Low Dose Rate Radiation Induced Severe DNA Damages on H520 Lung Cancer Cell[J]. Brachytherapy， 2015，14(2012)：S43.
     [34]Crabtree T D. Current options and controversies in the treatment of high-risk patients with early-stage non-small-cell lung cancer： a surgeon′s perspective[J]. Lung Cancer Management， 2012，1(1)：35-46.
     [35]Zhang S， Zheng Y， Yu P， et al. The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer[J]. J Cancer Res Clin Oncol， 2011，137(12)：1813-1822.
     [36]Li C， Yao L， Gong J， et al. Efficacy of gefitinib combined with 125I radioactive particles in the treatment of transplanted lung cancer tumors in nude mice[J]. Cardiovasc Intervent Radiol， 2020，43(9)：1364-1370.
     [37]Xu T， Peng W， Gu X， et al. Endobronchial ultrasound-guided iodine-125 radioactive seed implantation as a novel therapy for mediastinal tumors[J]. Cancer Biother Radiopharm， 2019，34(9)： 547.

快速检索引用检索图表检索高级检索